Holding
In Bio-Rad Labs., Inc. v. ITC, a Federal Circuit panel
affirmed the U.S. International Trade Commission's (ITC)
finding that Bio-Rad infringed patents, directed to gene sequencing
technology, owned by 10X Genomics Inc. In affirming the ITC, the
panel, inter alia, rejected Bio-Rad's defense that it
co-owned the asserted patents based on assignment provisions that
two named inventors signed while employees of Bio-Rad and its
predecessor, QuantaLife, even though the claimed inventions were
not made until after that employment.
Background
In 2010, the two named inventors, Drs. Benjamin Hindson and
Serge Saxonov, worked for QuantaLife, founded by Dr. Hindson. While
there, they each signed an agreement to “ disclose promptly
to the Company the full details of any and all ideas … that
Employee conceives, develops or creates alone or with the aid of
others during the term of Employee's employment with the
Company” and “(b) Employee shall assign to the